Gestational diabetes mellitus (GDM) is a serious pregnancy complication, in which women
without previously diagnosed diabetes develop chronic hyperglycemia during gestation. In …

Diabetic retinopathy (DR) is a global health burden. Screening for sight-threatening DR
(STDR) is the first cost-effective step to decrease this burden. We analyzed the similarities …

Results Overall, 49 (22%) and nine (4%) patients in the esaxerenone and placebo groups,
respectively, achieved urinary albumin-to-creatinine ratio remission (absolute difference …

Background Given the unique phenotype of type 2 diabetes in Japanese patients, novel
therapies such as oral semaglutide require evaluation in this population. PIONEER 9 aimed …

Background New glucose-lowering medications need to be investigated in east Asian
populations, as the clinical characteristics of type 2 diabetes differ between western and east …

Abstract Aims/Introduction To investigate the national trend in the prescription of first‐line
non‐insulin antidiabetic agents and total medical costs (TMCs) after prescribing the drug in …

OBJECTIVE The aim of this study was to investigate the efficacy and safety of imeglimin, the
first in a new class of oral antidiabetic agent, in Japanese patients with type 2 diabetes …

Introduction The present study aimed to evaluate the effects of flash glucose monitoring
(FGM) and conventional self-monitoring of blood glucose (SMBG) on glycemic control in …

Objectives”, explains how to select and use various test methods for evaluating disease
states, the prognosis, and the effects of treatment. References to the literature published …

Results Esaxerenone treatment at 1.25, 2.5, and 5 mg/d significantly reduced urinary
albumin-to-creatinine ratio by the end of treatment (38%, 50%, and 56%, respectively) …